Amalgamated Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47K Hold
3,992
﹤0.01% 1840
2025
Q1
$30K Buy
3,992
+200
+5% +$1.5K ﹤0.01% 1936
2024
Q4
$23K Hold
3,792
﹤0.01% 2059
2024
Q3
$19K Hold
3,792
﹤0.01% 2142
2024
Q2
$14K Hold
3,792
﹤0.01% 2260
2024
Q1
$12K Sell
3,792
-10,604
-74% -$33.6K ﹤0.01% 2339
2023
Q4
$71K Sell
14,396
-1,129
-7% -$5.57K ﹤0.01% 2110
2023
Q3
$85K Hold
15,525
﹤0.01% 2053
2023
Q2
$104K Buy
15,525
+3,883
+33% +$26K ﹤0.01% 2045
2023
Q1
$103K Sell
11,642
-2,891
-20% -$25.6K ﹤0.01% 2043
2022
Q4
$111K Buy
14,533
+320
+2% +$2.44K ﹤0.01% 2093
2022
Q3
$101K Buy
14,213
+14
+0.1% +$99 ﹤0.01% 2140
2022
Q2
$115K Sell
14,199
-10,714
-43% -$86.8K ﹤0.01% 2107
2022
Q1
$346K Buy
24,913
+2,285
+10% +$31.7K ﹤0.01% 1707
2021
Q4
$635K Buy
22,628
+2,944
+15% +$82.6K ﹤0.01% 1460
2021
Q3
$669K Sell
19,684
-1,212
-6% -$41.2K 0.01% 1442
2021
Q2
$854K Buy
20,896
+6,716
+47% +$274K 0.01% 1360
2021
Q1
$571K Sell
14,180
-1,238
-8% -$49.9K 0.02% 908
2020
Q4
$912K Sell
15,418
-6
-0% -$355 0.03% 599
2020
Q3
$750K Buy
15,424
+671
+5% +$32.6K 0.03% 613
2020
Q2
$714K Sell
14,753
-1,558
-10% -$75.4K 0.03% 606
2020
Q1
$453K Buy
+16,311
New +$453K 0.01% 956